China NMPA Drug Inspection - Guiyang Daosheng Health Industry Co., Ltd. - Acanthopanax senticosus
China NMPA drug inspection for Guiyang Daosheng Health Industry Co., Ltd. published December 22, 2020. Drug: Acanthopanax senticosus. On December 22, 2020, the Guizhou Provincial Drug Administration released its third drug quality announcement of the yea
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
China NMPA drug inspection for Guiyang Daosheng Health Industry Co., Ltd. published December 22, 2020. Drug: Acanthopanax senticosus. On December 22, 2020, the Guizhou Provincial Drug Administration released its third drug quality announcement of the yea
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox